Judy E. Harrison

409 total citations
6 papers, 202 citations indexed

About

Judy E. Harrison is a scholar working on Physiology, Pulmonary and Respiratory Medicine and Immunology and Allergy. According to data from OpenAlex, Judy E. Harrison has authored 6 papers receiving a total of 202 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Physiology, 5 papers in Pulmonary and Respiratory Medicine and 2 papers in Immunology and Allergy. Recurrent topics in Judy E. Harrison's work include Asthma and respiratory diseases (6 papers), Respiratory and Cough-Related Research (5 papers) and Inhalation and Respiratory Drug Delivery (2 papers). Judy E. Harrison is often cited by papers focused on Asthma and respiratory diseases (6 papers), Respiratory and Cough-Related Research (5 papers) and Inhalation and Respiratory Drug Delivery (2 papers). Judy E. Harrison collaborates with scholars based in United States, United Kingdom and Belgium. Judy E. Harrison's co-authors include K. B. Nolop, Robert Berkowitz, John J. Murray, S. David Miller, James P. Kemp, Stephen T. Holgate, Syed Hasan Arshad, Paul Stryszak, Michael B. Lawrence and W. Ritter and has published in prestigious journals such as Journal of Allergy and Clinical Immunology, Annals of Allergy Asthma & Immunology and American Journal of Therapeutics.

In The Last Decade

Judy E. Harrison

6 papers receiving 186 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Judy E. Harrison United States 6 173 138 57 14 11 6 202
Maxim Kots Italy 4 167 1.0× 156 1.1× 12 0.2× 1 0.1× 5 0.5× 18 174
Pilar Resano Spain 4 66 0.4× 45 0.3× 3 0.2× 15 1.4× 6 144
O. MORI Japan 4 13 0.1× 3 0.0× 22 0.4× 4 0.3× 10 0.9× 11 96
Matthew Walzer United States 5 28 0.2× 4 0.0× 53 0.9× 6 0.4× 10 0.9× 11 115
Nuria Feu-Collado Spain 5 72 0.4× 93 0.7× 1 0.0× 3 0.3× 8 155
Annika Volke Estonia 6 39 0.2× 3 0.0× 39 0.7× 3 0.2× 7 95
Ivan Krezić Croatia 9 25 0.1× 31 0.2× 11 0.8× 2 0.2× 17 165
Chris P. Doe Spain 3 30 0.2× 22 0.2× 2 0.0× 2 0.1× 3 67
Eluisa Perna Belgium 4 30 0.2× 10 0.1× 4 0.3× 2 0.2× 10 112
Minyoung Cho United States 3 40 0.2× 40 0.3× 2 0.1× 3 0.3× 6 97

Countries citing papers authored by Judy E. Harrison

Since Specialization
Citations

This map shows the geographic impact of Judy E. Harrison's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Judy E. Harrison with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Judy E. Harrison more than expected).

Fields of papers citing papers by Judy E. Harrison

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Judy E. Harrison. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Judy E. Harrison. The network helps show where Judy E. Harrison may publish in the future.

Co-authorship network of co-authors of Judy E. Harrison

This figure shows the co-authorship network connecting the top 25 collaborators of Judy E. Harrison. A scholar is included among the top collaborators of Judy E. Harrison based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Judy E. Harrison. Judy E. Harrison is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
1.
Nathan, Robert A., Anjuli Nayak, David F. Graft, et al.. (2001). Mometasone furoate: efficacy and safety in moderate asthma compared with beclomethasone dipropionate. Annals of Allergy Asthma & Immunology. 86(2). 203–210. 44 indexed citations
2.
Holgate, Stephen T., Syed Hasan Arshad, Paul Stryszak, & Judy E. Harrison. (2000). Mometasone furoate antagonizes AMP-induced bronchoconstriction in patients with mild asthma. Journal of Allergy and Clinical Immunology. 105(5). 906–911. 26 indexed citations
3.
Kemp, James P., Robert Berkowitz, S. David Miller, et al.. (2000). Mometasone furoate administered once daily is as effective as twice-daily administration for treatment of mild-to-moderate persistent asthma. Journal of Allergy and Clinical Immunology. 106(3). 485–492. 70 indexed citations
4.
Kaiser, Harold B., Charles H. Banov, David I. Bernstein, et al.. (1998). Comparative Efficacy and Safety of Once-Daily Versus Twice-Daily Loratadine-Pseudoephedrine Combinations Versus Placebo in Seasonal Allergic Rhinitis. American Journal of Therapeutics. 5(4). 245–252. 13 indexed citations
5.
Prenner, Bruce M., Paul Chervinsky, Frank C. Hampel, et al.. (1996). Double-strength beclomethasone dipropionate (84 μg/spray) aqueous nasal spray in the treatment of seasonal allergic rhinitis. Journal of Allergy and Clinical Immunology. 98(2). 302–308. 24 indexed citations
6.
Johnston, Sebastian L., Sandra R. Smith, Judy E. Harrison, W. Ritter, & Peter Howarth. (1993). The effect of BAY u 3405, a thromboxane receptor antagonist, on prostaglandin D2-induced nasal blockage. Journal of Allergy and Clinical Immunology. 91(4). 903–909. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026